Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.

B Lachmann - The European Respiratory journal. Supplement, 1989 - europepmc.org
This brief review describes the pathogenesis of the adult respiratory distress syndrome
(ARDS) and the rationale for surfactant replacement therapy. In four animal models in which …

Inactivation of pulmonary surfactant and the treatment of acute lung injuries

H William Taeusch, Kevin MW … - Pediatric Pathology & …, 2001 - Taylor & Francis
Inactivation of pulmonary surfactant may be important in acute lung injury and acute
respiratory distress syndrome. Treatment of surfactant dysfunction by instilling exogenous …

[引用][C] Surfactant replacement therapy in the experimental adult respiratory distress syndrome (ARDS)

B Lachmann, T Fujiwara, S Chida, T Morita, M Konishi… - Pulmonary Surfactant …, 1983

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials

JW Logan, FR Moya - Therapeutics and Clinical Risk Management, 2009 - Taylor & Francis
Introduction: Available literature suggests that the advantage of animal-derived surfactants
over first-generation synthetic agents derives from the presence of surface-active proteins …

Surfactant biology and clinical application

SE Poynter, AM LeVine - Critical care clinics, 2003 - criticalcare.theclinics.com
Pulmonary surfactant is a highly surface-active material that lines the alveolar surface of the
lung. The major function of pulmonary surfactant is the reduction of surface tension at the air …

Expanded uses of surfactant therapy

TE Wiswell - Clinics in perinatology, 2001 - perinatology.theclinics.com
Pulmonary surfactant is a complex and highly surface-active material necessary for
sustaining life by lowering surface tension to assist alveolar expansion, allowing gas …

The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality

H Yapıcıoğlu, D Yıldızdaş, İ Bayram, Y Sertdemir… - Pulmonary …, 2003 - Elsevier
Purpose. The aim of this prospectively designed study was to investigate the efficacy of
surfactant (S) for acute respiratory distress syndrome (ARDS) in children. Materials and …

Surfactant replacement therapy in preterm infants: a European survey

AH Van Kaam, AP De Jaegere, D Borensztajn… - Neonatology, 2011 - karger.com
Background: Exogenous surfactant is an undisputed treatment for neonatal respiratory
distress syndrome but its efficacy is highly dependent on the treatment strategy. International …

Overview of surfactant replacement trials

GK Suresh, RF Soll - Journal of perinatology, 2005 - nature.com
Clinical trials have evaluated the overall efficacy of surfactant therapy, as well as the relative
efficacy of different surfactant preparations, the optimal timing of administration and the …

Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?

S Sinha, F Moya, SM Donn - Current opinion in pediatrics, 2007 - journals.lww.com
Surfactant for respiratory distress syndrome: are there impo... : Current Opinion in Pediatrics
Surfactant for respiratory distress syndrome: are there important clinical differences among …